ABBV vs AMD: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Advanced Micro Devices, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-24.
AbbVie Inc. · Healthcare
$261.70
-1.0% upside to fair value
Med Conviction
Grade C
High Quality
VS
Advanced Micro Devices, Inc. · Technology
$614.61
-13.7% upside to fair value
Med Conviction
Grade C
QuantHub Verdict
ABBV has more upside to fair value
(-1.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
AMD |
| Current Price |
$261.70 |
$614.61 |
| Fair Value Estimate |
$259.04 |
$530.25 |
| Upside to Fair Value |
-1.0%
|
-13.7%
|
| Market Cap |
$462.4B |
$1,002.2B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
93.4x
|
| Price / Sales |
7.2x
|
24.3x
|
| Price / FCF |
23.6x
|
119.3x
|
| Revenue Growth YoY |
+10.2%
|
+50.1%
|
| Gross Margin |
71.5%
|
53.2%
|
| Operating Margin |
29.3%
|
15.7%
|
| Return on Equity |
-136.5%
|
10.1%
|
| Dividend Yield |
2.61% |
0% |
| FCF Yield |
4.25%
|
0.84%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
AbbVie is a diversified branded-biopharma company spanning immunology, neuroscience, oncology and aesthetics, with high-margin TTM economics including a 71.5% gross margin and 29.3% operating margin. Its successor immunology franchises are performing strongly: Q2 2026 revenue rose 10.2% year over year, with Skyrizi up 24.4% to $5.505 billion and Rinvoq up 24.5% to $2.525 billion, helping offset a…
Advanced Micro Devices designs x86 CPUs, GPUs, and data-center accelerators across two segments, Computing and Graphics and Enterprise, Embedded and Semi-Custom, with 31,000 employees and a $1.002 trillion market capitalization at $614.61 per share. The business quality is genuinely improving: revenue grew 50.1% year over year in the most recent quarter, earnings grew 163.4% year over year in the…
Accumulation Zones
| Metric |
ABBV |
AMD |
| Zone Low |
$194.28 |
$397.69 |
| Zone High |
$220.18 |
$450.71 |
| In Buy Zone? |
No
|
No
|